Atlas Trials

A Study to Assess the Effect of Tocilizumab Plus Methotrexate on Safety and Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis

Clinical trial NCT00754572 · COMPLETED

Trial details

NCT number
NCT00754572
Sponsor
Hoffmann-La Roche
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Rheumatoid Arthritis
Start date
2009-02-01
Primary completion
2012-10-01
Enrollment
418

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.